TrialNeuro-oncology2017

Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas.

Regina I Jakacki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.